Correction to: Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial

被引：0
|
作者：
Shubhadeep D. Sinha
Vamsi Krishna Bandi
Bala Reddy Bheemareddy
Pankaj Thakur
Sreenivasa Chary
Kalpana Mehta
Vikranth Reddy Pinnamareddy
Rajendra Pandey
Subhramanyam Sreepada
Santosh Durugkar
机构：
[1] Clinical Development and Medical Affairs,Department of Nephrology
[2] Hetero Group,Department of Nephrology
[3] Hetero Corporate,undefined
[4] B.L.Y Nair Hospital,undefined
[5] Care Hospitals,undefined
[6] Institute of Post Graduate Medical Education and Research Kolkata,undefined
[7] Sri Raghavendra Hospital,undefined
[8] Ashwini Hospital and Ramakanth Heart Care Center,undefined
来源：
BMC Nephrology | / 20卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Following publication of the original article [1], the authors reported errors in the presentation of Tables 2, 4 and 5.
引用
收藏
相关论文
共 50 条
  • [1] Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial
    Shubhadeep D. Sinha
    Vamsi Krishna Bandi
    Bala Reddy Bheemareddy
    Pankaj Thakur
    Sreenivasa Chary
    Kalpana Mehta
    Vikranth Reddy Pinnamareddy
    Rajendra Pandey
    Subhramanyam Sreepada
    Santosh Durugkar
    BMC Nephrology, 20
  • [2] Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial
    Sinha, Shubhadeep D.
    Bandi, Vamsi Krishna
    Bheemareddy, Bala Reddy
    Thakur, Pankaj
    Chary, Sreenivasa
    Mehta, Kalpana
    Pinnamareddy, Vikranth Reddy
    Pandey, Rajendra
    Sreepada, Subhramanyam
    Durugkar, Santosh
    BMC NEPHROLOGY, 2019, 20 (1)
  • [3] Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial (vol 20, 90, 2019)
    Sinha, Shubhadeep D.
    Bandi, Vamsi Krishna
    Bheemareddy, Bala Reddy
    Thakur, Pankaj
    Chary, Sreenivasa
    Mehta, Kalpana
    Pinnamareddy, Vikranth Reddy
    Pandey, Rajendra
    Sreepada, Subhramanyam
    Durugkar, Santosh
    BMC NEPHROLOGY, 2019, 20 (01)
  • [4] DARBEPOETIN ALFA, ONCE MONTHLY DOSING, CORRECTS ANEMIA IN CHRONIC KIDNEY DISEASE PATIENTS NOT ON DIALYSIS: A RANDOMIZED PHASE III STUDY
    Ferenczi, Sandor
    Roger, Simon
    Malecki, Robert
    Farouk, Mourad
    Dellanna, Frank
    Thomas, Mark
    Manamley, Nick
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 364 - 364
  • [5] COST CONSEQUENCE ANALYSIS OF DARBEPOETIN ALFA FOR THE TREATMENT OF ANEMIA DUE TO CHRONIC KIDNEY DISEASE (CKD) IN GREECE
    Kourlaba, G.
    Boletis, I
    Goumenos, D.
    Iatrou, C.
    Papagiannopoulou, V
    Tritaki, G.
    Maniadakis, N.
    VALUE IN HEALTH, 2014, 17 (07) : A468 - A469
  • [6] Efficacy and Safety of Daprodustat for Treatment of Anemia of Chronic Kidney Disease in Incident Dialysis Patients A Randomized Clinical Trial
    Singh, Ajay K.
    Cizman, Borut
    Carroll, Kevin
    McMurray, John J., V
    Perkovic, Vlado
    Jha, Vivekanand
    Johansen, Kirsten L.
    Lopes, Renato D.
    Macdougall, Iain C.
    Obrador, Gregorio T.
    Waikar, Sushrut S.
    Wanner, Christoph
    Wheeler, David C.
    Wiecek, Andrzej
    Stankus, Nicole
    Strutz, Frank
    Blackorby, Allison
    Cobitz, Alexander R.
    Meadowcroft, Amy M.
    Paul, Gitanjali
    Ranganathan, Prerna
    Sedani, Sangeeta
    Solomon, Scott
    JAMA INTERNAL MEDICINE, 2022, 182 (06) : 592 - 602
  • [7] Efficacy and safety of darbepoetin alfa injection replacing epoetin alfa injection for the treatment of renal anemia in Chinese hemodialysis patients: A randomized, open-label, parallel-group, noninferiority phase III trial
    Liu Bicheng
    Chen Nan
    Zhao Jinghong
    Yin Aiping
    Wu Xiongfei
    Xing Changying
    Jiang Gengru
    Fu Junzhou
    Wang Mei
    Wang Rong
    Niu Jianying
    Fu Ping
    Ni Zhaohui
    Hou Fanfan
    Zhao Jiuyang
    Chen Jing
    Chen Yuqing
    Shi Wei
    Chen Jianghua
    Li Wenge
    Xu Gang
    Zhong Ling
    Liu Wenhu
    Ding Guohua
    Kondo Yuichiro
    Yue Changhe
    Mei Changlin
    慢性疾病与转化医学（英文）, 2022, 08 (02) : 134 - 144
  • [8] Efficacy and safety of darbepoetin alfa for anemia in children with chronic kidney disease: a multicenter prospective study in Japan
    Motoshi Hattori
    Osamu Uemura
    Hiroshi Hataya
    Shuichi Ito
    Masataka Hisano
    Toshiyuki Ohta
    Shuichiro Fujinaga
    Tomoo Kise
    Yoshimitsu Gotoh
    Akira Matsunaga
    Naoko Ito
    Tadao Akizawa
    Clinical and Experimental Nephrology, 2014, 18 : 634 - 641
  • [9] Efficacy and safety of darbepoetin alfa for anemia in children with chronic kidney disease: a multicenter prospective study in Japan
    Hattori, Motoshi
    Uemura, Osamu
    Hataya, Hiroshi
    Ito, Shuichi
    Hisano, Masataka
    Ohta, Toshiyuki
    Fujinaga, Shuichiro
    Kise, Tomoo
    Gotoh, Yoshimitsu
    Matsunaga, Akira
    Ito, Naoko
    Akizawa, Tadao
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2014, 18 (04) : 634 - 641
  • [10] Efficacy and safety of CKD-11101 (darbepoetin-alfa proposed biosimilar) compared with NESP in anaemic chronic kidney disease patients not on dialysis
    Lee, Jong Hoon
    Chung, Byung Ha
    Joo, Kwon Wook
    Shin, Sug Kyun
    Kim, Yong-Lim
    Na, Ki Young
    Do, Jun-Young
    Park, Su-Kil
    Shin, Byung Chul
    Lee, Jong Soo
    Kim, Yang-Wook
    Kim, Soo Wan
    Lee, Kang Wook
    Kang, Gun Woo
    An, Won Suk
    Shin, Gyu-Tae
    Han, Seungyeup
    Yang, Chul Woo
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (06) : 1111 - 1118
12345